• Thursday, December 01, 2022

INDIA

India’s Cipla to price remdesivir version for Covid-19 under $66

INDIAN drugmaker Cipla Ltd will price its generic version of Gilead Sciences Inc’s antiviral drug remdesivir for use in Covid-19 patients at less than 5,000 rupees ($66), the company said.…